Clinical Trial

A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy

Study acronym: REFILLPAC-HYPO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary goal of this study is to assess the impact of an app that reminds patients treated with hypofractionated radiotherapy (HF-RT) for prostate cancer to drink water prior to each radiotherapy session on the number of bladder volumes \<200 ml during the HF-RT course and to demonstrate that this number is lower than without using an app (historical control group).
Trial Details
NCT Number NCT06784115
Lead Sponsor University Hospital Schleswig-Holstein
Collaborators: University of Southern Denmark, University of the Basque Country (UPV/EHU)
Conditions Prostate Cancer Patients Treated by Radiotherapy
Enrollment 27 participants
Start Date 2025-02-15
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-20